Recent Microbiome Study Finds that Shoreline Biome Products Differentiate Closely Related Gut Bacteria in Premature Infants
Share Article FARMINGTON, Conn. (PRWEB) February 18, 2021 Products from Shoreline Biome demonstrated high-resolution tracking of specific bacterial strains in a recent microbiome study, the results of which are being applied to better understand how pathogens and commensals become established in premature infants in neonatal intensive care units (NICU), with the goal of improving outcomes for premature infants.
Shoreline Biome is a microbiome research company based in Farmington that develops tools for characterizing microbiome populations down to the strain level.
The research article, titled High-Resolution Differentiation of Enteric Bacteria in Premature Infant Fecal Microbiomes Using a Novel rRNA Amplicon, was published February 16, 2021 in mBio. The study describes how Shoreline Biom